Show your working.
Good health tools should explain where their ideas come from—and where the evidence stops.
Your numbers,
with a point of comparison.
Biomarker Club benchmarks put each supported result beside a clear comparison point. Open a marker to see the source, the reasoning, and whether the point comes from guidance, a working convention or a laboratory interval.
How Club ratings work.
AI rates supported numeric results from 0–100 using the benchmark, related markers and available context. 85–100 means favorable or adequate; 65–84 means broadly reassuring with a meaningful caveat; 40–64 means worth a closer look; 0–39 means priority attention. These are exploratory product ratings, not risk percentages or validated measurements of longevity.
The overall score needs at least five rated markers and gives more weight to supported material findings than repeated or weak reference comparisons. Written results and incompatible measurements stay visible without entering the score. A laboratory critical flag takes priority over an overall rating.
A lab reference anchor is a midpoint or boundary for orientation. Moving closer to it does not automatically earn a better rating. Adequate results can rate equally well across a range; a benchmark is not a personal treatment target.
A published calculation.
Clinical Phenotypic Age uses chronological age and nine blood measurements. We use the corrected published equation, explicit unit conversions and no guessed missing inputs.
It is distinct from DNA methylation PhenoAge and DunedinPACE. Changing a calculated age does not establish that an intervention extends life.
Read the equationStart with the evidence. 51
What stays true
across every report.
- 01An AI-generated summary or 1–100 index is experimental, not a validated longevity measurement, diagnosis, prognosis or treatment recommendation.
- 02Do not fabricate an optimal scalar when evidence only supports a clinical threshold, a reference interval, an association, or no target.
- 03Use the reporting laboratory's reference interval, specimen, method and units; review uncertain imports before interpretation.
- 04Do not infer causation from a supplement change followed by a biomarker change, or treat community popularity as evidence of benefit.
- 05Do not suggest changes to prescription medicines or prescribe supplements. Preserve important out-of-range findings independently of any summary score.
- 06Do not claim that lowering a model age proves rejuvenation or extends lifespan. Compare like panels and account for illness and measurement variability.
Our reading list.
Adult haematology reference ranges
Published adult CBC intervals include sex-specific hemoglobin, hematocrit and red-cell counts. Midpoints are educational reference anchors, not evidence of optimal longevity.
Laboratory contextManchester University NHS Foundation TrustHaematology User Guide: blood count intervals
The adult RDW-CV interval is 11–14%. This assay-specific interval does not establish a biological-age target.
Laboratory contextNorth West Anglia NHS Foundation TrustClinical biochemistry reference ranges
Published chemistry intervals include electrolytes, albumin, total protein, bilirubin, thyroid and nutritional measurements, with age or sex strata where relevant. Use the original reporting laboratory interval when available.
Laboratory contextNorth Bristol NHS TrustClinical biochemistry equipment and reference range changes
The laboratory reports CRP below 5 mg/L, serum iron 11–32 µmol/L and serum folate 3–20 µg/L. Platform changes can materially change assay intervals; laboratory midpoint comparisons are not health targets.
Laboratory contextUniversity Hospitals of North MidlandsAlkaline phosphatase reference interval
The published adult ALP interval is 30–130 U/L. Growth, pregnancy and bone or liver context affect interpretation.
Laboratory contextNorth Bristol NHS TrustSodium test information
The serum sodium interval is 133–146 mmol/L. Its midpoint is only a reference anchor, not a value to pursue through fluid or salt changes.
Laboratory contextNorth Bristol NHS TrustChloride test information
The serum chloride interval is 95–108 mmol/L. Interpret electrolyte patterns rather than distance from the midpoint.
Laboratory contextNorth Bristol NHS TrustBicarbonate test information
The serum bicarbonate interval is 22–29 mmol/L. Sample handling and blood-gas versus serum measurement context matter.
Laboratory contextNorth Bristol NHS TrustUrea test information
The adult serum urea interval is 2.5–7.8 mmol/L. BUN mass units express nitrogen rather than the whole urea molecule.
Laboratory contextNorth West London PathologyHomocysteine test information
The reported laboratory interval is 5–15 µmol/L. A midpoint comparison is not evidence that lowering homocysteine to that number extends life.
Laboratory contextNorth West London PathologyApolipoprotein B test information
The laboratory lists male 0.41–1.06 g/L and female 0.47–0.99 g/L reference intervals. These are not individualized cardiovascular treatment goals.
Laboratory contextNIH MedlinePlusTriglycerides: adult categories
The usual adult category boundary is 150 mg/dL, with values of at least 500 mg/dL in the very-high category. A category boundary is not a universal longevity optimum.
Clinical guidanceLevine et al., Aging (2018)An epigenetic biomarker of aging for lifespan and healthspan
Clinical Phenotypic Age uses nine blood measurements and chronological age. DNAm PhenoAge is a separate methylation-based model; neither establishes ideal values for individual biomarkers.
Validated associationLiu et al., PLOS Medicine (2018)A new aging measure captures morbidity and mortality risk across diverse subpopulations
Independent NHANES validation included ages 20–84, with oldest participants top-coded at 85. PhenoAgeAccel is a cohort regression residual, not simply age subtraction.
Validated associationLiu et al., PLOS Medicine (2019)Correction: Phenotypic Age equation
The corrected equation explicitly includes mortality transformation M and a denominator of 0.09165. This implementation follows the corrected published coefficients.
Validated associationBelsky et al., eLife (2022)DunedinPACE, a DNA methylation biomarker of the pace of aging
DunedinPACE requires DNA methylation assay data. A routine blood panel cannot produce a DunedinPACE value.
Validated associationRejuvenation OlympicsRejuvenation Olympics: Science
The competition describes epigenetic aging measurements. A leaderboard is not clinical evidence for a universal optimal blood-marker value.
ExploratoryNIH MedlinePlusHow to understand your lab results
Reference intervals vary by laboratory and patient context. A result inside the interval does not rule out illness; one outside it does not establish a diagnosis.
Laboratory contextNIH MedlinePlusComplete blood count
Blood counts need context including hydration, medication, infection and other measurements. Cell counts are not monotonic longevity targets.
Laboratory contextNIH MedlinePlusMean corpuscular volume
Red-cell size helps assess anemia patterns alongside other measurements; a lower MCV is not inherently healthier.
Laboratory contextNIH MedlinePlusRed cell distribution width
RDW describes variation in red-cell size and is interpreted with other CBC measurements.
Laboratory contextNIH MedlinePlusComprehensive metabolic panel
Metabolic measurements assess different organ systems and fluid balance; each requires its reporting laboratory's context.
Laboratory contextNIH MedlinePlusAlbumin blood test
Albumin can vary with liver and kidney conditions, inflammation and hydration. Maximizing albumin is not an established longevity intervention.
Laboratory contextNIH MedlinePlusAlkaline phosphatase
ALP arises from several tissues, including liver and bone. Its source and clinical context matter.
Laboratory contextNIH MedlinePlusLiver function tests
Liver panel patterns and medical history are more informative than an isolated enzyme value; abnormal results do not identify one cause.
Laboratory contextNIH NIDDKDiabetes tests and diagnosis
For nonpregnant adults, HbA1c 5.7% and 6.5%, and fasting plasma glucose 100 and 126 mg/dL, are assessment thresholds. Diagnosis usually requires confirmation. These are not longevity optima.
Clinical guidanceNIH NIDDKThe A1C test and diabetes
A1c reflects longer-term glycemia but can be misleading with altered red-cell lifespan, some hemoglobin variants, pregnancy and other conditions.
Clinical guidanceNGSPIFCC standardization of HbA1c
NGSP percent = 0.09148 × IFCC mmol/mol + 2.152. HbA1c conversion needs an intercept, not just a scaling factor.
Laboratory contextAmerican College of Cardiology / American Heart Association2026 guideline for managing dyslipidemia
LDL treatment goals depend on cardiovascular risk: examples include below 100, 70 or 55 mg/dL. Lp(a) risk thresholds include 125 nmol/L or 50 mg/dL; apoB helps selected risk assessments.
Clinical guidanceAmerican College of CardiologyLipoprotein(a): testing and guideline recommendations
Lp(a) mass and particle-concentration units cannot be converted with one universally reliable factor because particle size varies.
Clinical guidanceNIH MedlinePlusCholesterol levels
A lipid panel is interpreted alongside cardiovascular risk factors. Common desirable thresholds are not personalized treatment targets.
Laboratory contextNIH MedlinePlusC-reactive protein test
CRP reflects inflammation without identifying its cause. Standard and high-sensitivity assays differ in useful low-level measurement.
Laboratory contextCDC / AHA scientific statementMarkers of inflammation and cardiovascular disease
Historic hsCRP relative-risk categories are below 1, 1–3 and above 3 mg/L in appropriate stable clinical settings; marked elevation needs assessment for other inflammation.
Clinical guidanceKDIGO2024 CKD evaluation and management guideline
Kidney assessment combines eGFR, albuminuria and persistence. Creatinine is affected by non-kidney determinants; one result cannot establish chronic kidney disease.
Clinical guidanceAmerican Thyroid AssociationThyroid function tests
TSH and free thyroid hormones need interpretation together. Pregnancy, illness, medication and assay interference affect interpretation.
Clinical guidanceAmerican Thyroid AssociationBiotin interference with thyroid tests
Biotin supplements can distort some thyroid assay results. Users should disclose supplements to their clinician and laboratory.
Laboratory contextWorld Health Organization (2020)Ferritin concentrations to assess iron status
Ferritin assessment depends on inflammation and population context. An iron-deficiency cutoff is not a universal desirable ferritin value.
Clinical guidanceNIH MedlinePlusIron tests
Serum iron, ferritin and binding measurements answer different questions. Timing, menstrual loss, inflammation and other results affect interpretation.
Laboratory contextNIH Office of Dietary SupplementsVitamin D: health professional fact sheet
NASEM considers 25(OH)D of at least 20 ng/mL adequate for most people and above 50 ng/mL potentially concerning. These are nutritional guidance, not longevity optima.
Clinical guidanceEndocrine Society (2024)Vitamin D prevention guideline
The guideline could not establish blood-level targets for disease prevention and advises against routine testing in generally healthy populations.
Clinical guidanceNIH Office of Dietary SupplementsVitamin B12: health professional fact sheet
Low cutoffs depend on the assay, often 200–250 pg/mL. Borderline values may need methylmalonic acid assessment; higher serum B12 is not proven to extend life.
Clinical guidanceNIH Office of Dietary SupplementsFolate: health professional fact sheet
Serum folate above 3 ng/mL suggests adequacy, but recent intake affects it. Serum and red-cell folate are distinct tests.
Clinical guidanceNIH MedlinePlusMagnesium blood test
Serum magnesium measures a small fraction of body magnesium. Low and high values can both be clinically relevant.
Laboratory contextNIH MedlinePlusUric acid test
Urate assessment relates to conditions including gout and kidney stones. Disease-treatment targets are not established general longevity targets.
Laboratory context